McGuire Andrew T, Glenn Jolene A, Lippy Adriana, Stamatatos Leonidas
Seattle Biomedical Research Institute, Seattle, Washington, USA.
J Virol. 2014 Mar;88(5):2645-57. doi: 10.1128/JVI.03228-13. Epub 2013 Dec 18.
Broadly neutralizing antibodies (bNAbs) against HIV-1 are generated during HIV-1-infection but have not yet been elicited by immunization with recombinant forms of the viral envelope glycoprotein (Env; the target of anti-HIV-1 neutralizing antibodies). A particular type of bNAb targets the CD4-binding site (CD4-BS) region of Env. These antibodies are derived from a limited number of VH/VL genes and can bind to and neutralize diverse HIV-1 strains. Recent reports have demonstrated the limited potential of Env to activate B cells expressing the germline B cell receptor (BCR) forms of anti-CD4-BS bNAbs. A potential reason for the lack of elicitation of anti-CD4-BS bNAbs by Env immunogens is the absence of stimulation of naive B cells expressing the germline BCRs of such antibodies. Several bNAbs have been isolated from HIV-1-infected subjects that target other structurally conserved regions of Env. How frequently Env immunogens stimulate the germline BCRs that give rise to bNAbs that target Env regions other than the CD4-BS is not well understood. Here, we investigated the interactions between diverse Envs and the BCRs of known bNAbs targeting not only the CD4-BS but also conserved elements of the second and third variable Env regions. Our results indicate that Env is generally ineffective in engaging germline BCRs of bNAbs irrespective of their epitope target. Potentially, this is the result of viral evolutionary mechanisms adopted to escape broadly neutralizing antibody responses. Our results also suggest that a single Env capable of activating germline BCRs that target distinct Env epitopes will be very difficult to identify or to design.
Broadly neutralizing antibodies against HIV-1 are thought to be an important component of the immune responses that a successful vaccine should elicit. Broadly neutralizing antibodies are generated by a subset of those infected by HIV-1, but so far, they have not been generated by immunization with recombinant Envelope (Env, the target of anti-HIV-1 neutralizing antibodies). Here, we provide evidence that the inability of Env to elicit the production of broadly neutralizing antibodies is due to the inability of diverse Envs to engage the germline B cell receptor forms of known broadly neutralizing antibodies.
针对HIV-1的广泛中和抗体(bNAbs)在HIV-1感染期间产生,但尚未通过用病毒包膜糖蛋白(Env;抗HIV-1中和抗体的靶标)的重组形式进行免疫诱导产生。一种特定类型的bNAb靶向Env的CD4结合位点(CD4-BS)区域。这些抗体源自有限数量的VH/VL基因,能够结合并中和多种HIV-1毒株。最近的报告表明,Env激活表达抗CD4-BS bNAb的胚系B细胞受体(BCR)形式的B细胞的潜力有限。Env免疫原未能诱导抗CD4-BS bNAb产生的一个潜在原因是缺乏对表达此类抗体胚系BCR的幼稚B细胞的刺激。已经从HIV-1感染的受试者中分离出几种靶向Env其他结构保守区域的bNAb。Env免疫原刺激产生靶向除CD4-BS之外的Env区域的bNAb的胚系BCR的频率尚不清楚。在这里,我们研究了多种Env与已知bNAb的BCR之间的相互作用,这些bNAb不仅靶向CD4-BS,还靶向Env第二和第三可变区域的保守元件。我们的结果表明,无论其表位靶标如何,Env通常都无法有效地与bNAb的胚系BCR结合。这可能是病毒为逃避广泛中和抗体反应而采用的进化机制的结果。我们的结果还表明,很难鉴定或设计出一种能够激活靶向不同Env表位的胚系BCR的单一Env。
针对HIV-1的广泛中和抗体被认为是成功疫苗应诱导的免疫反应的重要组成部分。广泛中和抗体由一部分HIV-1感染者产生,但到目前为止,通过重组包膜(Env,抗HIV-1中和抗体的靶标)免疫尚未产生。在这里,我们提供证据表明,Env无法诱导产生广泛中和抗体是由于多种Env无法与已知广泛中和抗体的胚系B细胞受体形式结合。